Aurinia Pharmaceuticals (AUPH) Technical (Analysis) Reports Aurinia Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Aurinia Pharmaceuticals (AUPH)
Technical Analysis Report for NASDAQ stock AUPH Aurinia Pharmaceuticals. Dated: 24 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock AUPH Aurinia Pharmaceuticals then click here. or read Experts views on Aurinia Pharmaceuticals or Forecast & share price targets of Aurinia Pharmaceuticals
Aurinia Pharmaceuticals Opened at 16.35 and Closed at: 16.28, which is 0.43% of previous session's close. It moved within a range of 16.20 and 16.42
The session was a Bearish session with an average volume of 431600, which is -140.92% of previous session's volumes.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Golden cross was found 2 days back on short term averages
A Dead cross was found 9 days back on short term averages
Support for tomorrow is 16.13 and resistance for tomorrow is 16.35
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 16.18, 16.08 resistance for tomorrow's hourly charts is 16.4, 16.52
10 Day SMA for Aurinia Pharmaceuticals (AUPH) is 16 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Aurinia Pharmaceuticals (AUPH) is 15.85 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Aurinia Pharmaceuticals (AUPH) is 14.59 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 13.31 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Aurinia Pharmaceuticals is 10.77 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Aurinia Pharmaceuticals is at 15.85 and 200 DMA is at 10.77, while 50 DMA and 100 DMA are at 14.59 and 13.31 respectively
Aurinia Pharmaceuticals (AUPH) moving average of 20 SMA is at 15.85 and 20 EMA is at 15.78
| Date | Closing Price | 20 SMA | 20 EMA |
| 24 Wed Dec | 16.28 | 15.85 | 15.78 |
| 23 Tue Dec | 16.21 | 15.85 | 15.73 |
| 22 Mon Dec | 16.31 | 15.85 | 15.68 |
| 19 Fri Dec | 16.18 | 15.82 | 15.61 |
| 18 Thu Dec | 15.91 | 15.76 | 15.55 |
| 17 Wed Dec | 15.79 | 15.73 | 15.51 |
Aurinia Pharmaceuticals (AUPH) moving average of 50 SMA is at 14.59 and 50 EMA is at 14.8
| Date | Closing Price | 50 SMA | 50 EMA |
| 24 Wed Dec | 16.28 | 14.59 | 14.8 |
| 23 Tue Dec | 16.21 | 14.49 | 14.74 |
| 22 Mon Dec | 16.31 | 14.39 | 14.68 |
| 19 Fri Dec | 16.18 | 14.29 | 14.61 |
| 18 Thu Dec | 15.91 | 14.2 | 14.55 |
| 17 Wed Dec | 15.79 | 14.11 | 14.49 |
Aurinia Pharmaceuticals (AUPH) moving average of 100 SMA is at 13.31 and 100 EMA is at 13.4
| Date | Closing Price | 100 SMA | 100 EMA |
| 24 Wed Dec | 16.28 | 13.31 | 13.4 |
| 23 Tue Dec | 16.21 | 13.27 | 13.34 |
| 22 Mon Dec | 16.31 | 13.21 | 13.28 |
| 19 Fri Dec | 16.18 | 13.14 | 13.22 |
| 18 Thu Dec | 15.91 | 13.07 | 13.16 |
| 17 Wed Dec | 15.79 | 13 | 13.1 |
Aurinia Pharmaceuticals (AUPH) moving average of 200 SMA is at 10.77 and 200 EMA is at 11.6
| Date | Closing Price | 200 SMA | 200 EMA |
| 24 Wed Dec | 16.28 | 10.77 | 11.6 |
| 23 Tue Dec | 16.21 | 10.73 | 11.55 |
| 22 Mon Dec | 16.31 | 10.69 | 11.5 |
| 19 Fri Dec | 16.18 | 10.65 | 11.45 |
| 18 Thu Dec | 15.91 | 10.61 | 11.4 |
| 17 Wed Dec | 15.79 | 10.57 | 11.35 |
Trillium Therapeutics has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Trillium Therapeutics, about 0.65% more returns!
Tandem Diabetes has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Tandem Diabetes, about 8.99% more returns!
China Sxt has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in China Sxt, about 8.3% more returns!
Aurinia Pharmaceuticals has performed better than Semler Scientific in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Siga Technologies has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Siga Technologies, about 4.36% more returns!
Aurinia Pharmaceuticals has performed better than Neurocrine Biosciences in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Merus N has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Merus N, about 1.4% more returns!
Kezar Life has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Kezar Life, about 2.81% more returns!
Iridex Corporation has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Iridex Corporation, about 20.55% more returns!
Heron Therapeutics has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Heron Therapeutics, about 14.84% more returns!
Aurinia Pharmaceuticals has performed better than Genprex Inc in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals has performed better than Galmed Pharmaceuticals in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Fortress Biotech has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Fortress Biotech, about 33.04% more returns!
Arrowhead Pharmaceuticals has performed better than Aurinia Pharmaceuticals in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 21.95% more returns!
Aurinia Pharmaceuticals has performed better than Anika Therapeutics in short term. Holding Aurinia Pharmaceuticals could be a better choice for now!
Aurinia Pharmaceuticals Technical analysis of indicators
Price action analysis of Aurinia Pharmaceuticals (AUPH) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Aurinia Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Aurinia Pharmaceuticals in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Aurinia Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Aurinia Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Aurinia Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 15.98 and Aurinia Pharmaceuticals AUPH stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Aurinia Pharmaceuticals AUPH stock. Volume based technical analysis of Aurinia Pharmaceuticals AUPH stock is negative.
Aurinia Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock AUPH Aurinia Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And AUPH Experts View which covers a lot of information including buying and selling signals
AUPH future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Aurinia Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Aurinia Pharmaceuticals (AUPH) Technical (Analysis) Reports Aurinia Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


